An update: the emerging evidence of complement involvement in COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An update: the emerging evidence of complement involvement in COVID-19
Authors
Keywords
-
Journal
MEDICAL MICROBIOLOGY AND IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-03
DOI
10.1007/s00430-021-00704-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complement blockade for TA-TMA: lessons learned from large pediatric cohort treated with eculizumab
- (2020) Sonata Jodele et al. BLOOD
- Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria
- (2020) Robert A. Brodsky et al. HAEMATOLOGICA
- Presumed Asymptomatic Carrier Transmission of COVID-19
- (2020) Yan Bai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
- (2020) Camilla Rothe et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
- (2020) Bo Shen et al. CELL
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Complement activation in patients with COVID-19: A novel therapeutic target
- (2020) Massimo Cugno et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The case of Complement activation in COVID-19 multiorgan impact
- (2020) Marina Noris et al. KIDNEY INTERNATIONAL
- Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
- (2020) Hua Su et al. KIDNEY INTERNATIONAL
- Clinical Characteristics of Covid-19 in New York City
- (2020) Parag Goyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children
- (2020) Francesco Licciardi et al. PEDIATRICS
- Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
- (2020) Cynthia Magro et al. Translational Research
- Red cell–bound antibodies and transfusion requirements in hospitalized patients with COVID-19
- (2020) Alessandra Berzuini et al. BLOOD
- COVID-19 and the Coombs test
- (2020) Jeanne E. Hendrickson et al. BLOOD
- Tackling COVID‐19 infection through complement‐targeted immunotherapy
- (2020) Sonata Jodele et al. BRITISH JOURNAL OF PHARMACOLOGY
- MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti‐MASP2 antibody narsoplimab
- (2020) S. Elhadad et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
- (2020) Sara Mastaglio et al. CLINICAL IMMUNOLOGY
- Rationale for targeting complement in COVID‐19
- (2020) Anastasia Polycarpou et al. EMBO Molecular Medicine
- Complement C5 inhibition in patients with COVID-19 - a promising target?
- (2020) Regis Peffault de Latour et al. HAEMATOLOGICA
- Endothelial Injury and Thrombotic Microangiopathy in COVID-19: Treatment with the Lectin-Pathway Inhibitor Narsoplimab
- (2020) Alessandro Rambaldi et al. IMMUNOBIOLOGY
- Epidemiology and clinical features of COVID-19: A review of current literature
- (2020) Juan A. Siordia JOURNAL OF CLINICAL VIROLOGY
- Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis
- (2020) Julien Carvelli et al. NATURE
- Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection
- (2020) Christoph B. Messner et al. Cell Systems
- Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
- (2020) Jia Yu et al. BLOOD
- Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
- (2020) Jan C. Holter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical promise of next-generation complement therapeutics
- (2019) Dimitrios C. Mastellos et al. NATURE REVIEWS DRUG DISCOVERY
- Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV
- (2018) Yuting Jiang et al. Emerging Microbes & Infections
- Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
- (2018) Lisa E. Gralinski et al. mBio
- Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial
- (2016) Fadi Fakhouri et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation
- (2016) Markus J. Harder et al. BLOOD
- Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
- (2013) C.M. Legendre et al. NEW ENGLAND JOURNAL OF MEDICINE
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complement and viral pathogenesis
- (2011) Kristina A. Stoermer et al. VIROLOGY
- The complement system
- (2010) J. Vidya Sarma et al. CELL AND TISSUE RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started